IT is intended here merely to give an outline of the results obtained in a large series of experiments performed in the study of the absorption and excretion of M.&B. 693 and of some of the toxic effects of that drug and Uleron. Experimental detail will not bte described.
the body fluids. The method used in the present investigation was that described by Werner (1939) .
M.&B. 693 is absorbed from the gastro-intestinal tract and appears in the bloodstream and urine within half an hour after its ingestion by mouth. The maximum concentration is reached in from two to five hours time, the maximum urinary output being delayed for from half an hour to five hours after the blood peak has been reached. After a single (lose of the drug, M.&B. 693 can still be detected in the blood for forty-eight to sixty hours and in the urine for eighty-four hours, whilst, with repeatedl (losage, it has been recovered from the blood thirty-six hours and from the urine sixty hours after the last dose, a point of importance in view of the toxicity of the drug. The output of the drug varies with diuresis, but large amounts of fluids appear to wash it through the bowel too rapidly for complete absorption from the intestine to take place, and the urinary output is thus considerably less than on a low fluid intake: Baines and Wien (1939) have shown that normally a small amount of the drug is excreted in the faeces, and it is likely that excretion, when large amounts of fluid are administered, is chiefly through the bowel. It will be mentioned later that in treating non-specific urinary infections, a fairly high concentration of the drug in the urine is necessary; where such a condition is being treated with M.&B. 693, therefore, fluids should not be given in excess. VVhere toxic manifestations appear following absorption of M.&B. 693, forcing fluids will tend to wash the drug out of the body. Increased fluid intake, however, does not appear to accelerate absorption from the gastro-intestinal tract as has been shown by others to occur with sulphanilamide (Marshall, 1939; Lucas, 1939) .
A blood concentration of 2.5 milligrammes per cent. has been found to be a reasonably satisfactory level in the treatment of most cases of gonococcal urethritis, and this concentration can be maintained by a dosage of two grammes per day following a heavier initial dose of three grammes during the first day's treatment.
The blood level varies with, though not in proportion to, the dosage, a reasonably steady blood level being maintained by repeated doses given at four-to five-hourly intervals during the period of administration of the drug. The concentration of the drug falls during the night, and in urgent cases where a steady blood level is desired, the last (lose of the drug should be given late at night and the first dose early the following morning, or an extra dose should be administered during the night.
The drug appears in the blood and urine partly as a free, active compound and partly as an acetylated, inert derivative. The amount of the free and acetylated cdrug varies conbsiderably, not only from patient to patient, but in the same patient from time to time. On an average, about twenty per cent. of the drug was found to be in the inactive form in the blood and about forty per cent. in the urine, though a much higher degree of acetylation sometimes occurs, figures rather lower than those recorded by other workers (Stokinger, 1939; Long and Feinstone, 1939 TOXIC MANIFEST'ATIONS. In common with sulphanilamide, both M.&B. 693 and Uleron show a high degree of toxicity. Many "minor" toxic reactions are common with M.&B. 693, especially nausea, flatulence, headache, and (particularly in females) vomiting. These "minor" reactions are much less common with Uleron. The use of both drugs, however, is often followed by more serious toxic manifestations, which are often missed or unrecognised. Of these, the most important are the effects of the drugs on the blood cells of the body and on the kidneys, whilst a less urgent, though often more alarming, toxic effect is the occurrence of skin rashes and drug fever following ingestion, especially of M.&B. (Sommer, 1938; Muller, 1938;  Adalja, 1939 ; and others); these reports included at least one fatal case (Tsao et al., 1939) . Experimental haematuria has also been produced (Gross and Cooper, 1939; Antopol and Robinson, 1939) . The cause of the phenomenon is still a matter of conjecture, but in the more severe cases at least, and in experimental animals, it would appear to be due to the deposit of needle-like crystals of the acetyl derivative of the drug in the urinary tracts of suspectible individuals. In the series of cases analysed personally, haematuria was found to be more common in M.&B.-693-treated patients, where the percentage of the acetylated drug in the urine was high. X-ray and blood-urea examinations in a number of cases where haematuria was seen, revealed no pathology of the renal tract, but the possibility of renal calculi following chemotherapy with M.&B. 693 and Uleron cannot be overlooked. Time alone will eitherprove or disprove tilis possibility, and it is not suggested that drugs as potent as those now in our possession should be discarded on this account; it is important, however, that they be used with due consideration to their toxic possibilities.
Where gross haematuria occurs, as in the case of other severe toxic manifestations, the drugs should be withheld and large amounts of fluids should be given in order to xvash the drug out of the tissues.
(3) EFFECTS ON THE SKIN.
The skin reactions observed may follow exposure to artificial or natural sunlight or may occur apart from such exposure. Skin rashes occurred in only four patients treated personally with M.&B. 693, and in only one of these patients was there any suggestion of light-sensitivity. In three cases the dosage was small, the rash appearing on the eighth morning from beginning of chemotherapy in one case and on the tenth morning in two cases. In the fourth case, the rash occurred on the fourteenth day from beginning a second course of the drug. In one case, the dermatitis was accompanied by drug fever, whilst in this case as well as in one other, considerable gastric upset was seen when the drug was being taken. The time factor was of interest in these cases and was similar to that found by Erskine (1939) and Thompson (1939) , the skin eruptions occurring in their cases between the eighth and txvelfth days of administration of the dlrug. It has been mentioned that toxic manifestationis often result f'ronm the accumulationi of the drug in the tissues, and such would appear tio be a possible explanation of 
